Malignant neoplasm of liver and intrahepatic bile ducts
- C22 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2024 edition of ICD-10-CM C22 became effective on October 1, 2023.
- This is the American ICD-10-CM version of C22 – other international versions of ICD-10 C22 may differ.
Use Additional
- code to identify:
- alcohol abuse and dependence (F10.-)
- hepatitis B (B16.-, B18.0-B18.1)
- hepatitis C (B17.1-, B18.2)
Type 1 Excludes
- malignant neoplasm of biliary tract NOS (C24.9)
- secondary malignant neoplasm of liver and intrahepatic bile duct (C78.7)
The following code(s) above C22 contain annotation back-references
that may be applicable to C22:
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
Code annotations containing back-references to C22:
- Applicable To: Z85.05